Microbial ecosystems therapeutics: a new paradigm in medicine?
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Increasing evidence indicates that the complex microbial ecosystem of the human intestine plays a critical role in protecting the host against disease. This review discusses gut dysbiosis (here defined as a state of imbalance in the gut microbial ecosystem, including overgrowth of some organisms and loss of others) as the foundation for several diseases, and the applicability of refined microbial ecosystem replacement therapies as a future treatment modality. Consistent with the concept of a ‘core’ microbiome encompassing key functions required for normal intestinal homeostasis, ‘Microbial Ecosystem Therapeutics’ (MET) would entail replacing a dysfunctional, damaged ecosystem with a fully developed and healthy ecosystem of ‘native’ intestinal bacteria. Its application in treating Clostridium difficile infection is discussed and possible applications to other diseases such as ulcerative colitis, obesity, necrotising enterocolitis, and regressive-type autism are reviewed. Unlike conventional probiotic therapies that are generally limited to a single strain or at most a few strains of bacteria ‘Microbial Ecosystem Therapeutics’ would utilise whole bacterial communities derived directly from the human gastrointestinal tract. By taking into account the intrinsic needs of the entire microbial ecosystem, MET would emphasise the rational design of healthy, resilient and robust microbial communities that could be used to maintain or restore human health. More than simply a new probiotic treatment, this emerging paradigm in medicine may lead to novel strategies in treating and managing a wide variety of human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“Although the mechanisms that link gut microbiota disturbance to behaviour are multifactorial and not yet completely defined, recently the vagus nerve has been demonstrated as a critical communication conduit between gut microbes and the brain (Bravo et al., 2011).”
BackgroundEcological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 2×
“The human gastrointestinal tract contains vast numbers of bacteria collectively called the intestinal microbiota (Ley et al., 2006a).”
BackgroundVrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X., Kubo, C., & Koga, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063388 · Cited by 2,735
Microbiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · cited 1×
“At the phylum level, contradictory results from different groups have made it difficult to ascertain an obesity signature (Duncan et al., 2008; Jumpertz et al., 2011; Ley et al., 2005, 2006b; Schwiertz et al., 2010; Turnbaugh et al., 2006).”
BackgroundBercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748 · cited 2×
“…infection with pathogens such as Citrobacter rodentium have been shown to modulate behaviour, with the former approach giving rise to a less anxious phenotype (Bercik et al., 2011) and the latter approach resulting in enhanced anxiety and stress-induced memory dysfunction (Gareau et al., 2011).”
BackgroundHuman colonic microbiota associated with diet, obesity and weight loss
Duncan, S. H., Lobley, G. E., Holtrop, G., Ince, J., Johnstone, A. M., Louis, P., & Flint, H. J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.155 · Cited by 1,222
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Pyrosequencing study of fecal microflora of autistic and control children
Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., Youn, E., Summanen, P. H., Granpeesheh, D., Dixon, D., et al. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2010.06.008 · Cited by 977
Bacterial infection causes stress-induced memory dysfunction in mice
Gareau, M. G., Wine, E., Rodrigues, D. M., Cho, J. H., Whary, M. T., Philpott, D. J., MacQueen, G., & Sherman, P. M. (2011) · Gut · doi:10.1136/gut.2009.202515 · Cited by 909 · cited 2×
“…infection with pathogens such as Citrobacter rodentium have been shown to modulate behaviour, with the former approach giving rise to a less anxious phenotype (Bercik et al., 2011) and the latter approach resulting in enhanced anxiety and stress-induced memory dysfunction (Gareau et al., 2011).”
BackgroundParracho, H. M., Bingham, M. O., Gibson, G. R., & McCartney, A. L. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46101-0 · Cited by 784 · cited 3×
“Interestingly, gastrointestinal disturbances are frequently co-reported in affected children (Parracho et al., 2005), as are altered urinary metabolite phenotypes, characteristic of metabolites originating from the gut microbiota (Clayton, 2012; Yap et al., 2010).”
BackgroundPetrof, E. O., Gloor, G. B., Vanner, S. J., Weese, S. J., Carter, D., Daigneault, M. C., Brown, E. M., Schroeter, K., & Allen-Vercoe, E. (2013) · Microbiome · doi:10.1186/2049-2618-1-3 · Cited by 731
Self-citationFecal microbiota transplantation and emerging applications
Borody, T. J., & Khoruts, A. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.244 · Cited by 677
Lin, H.-C., Su, B.-H., Chen, A.-C., Lin, T.-W., Tsai, C.-H., Yeh, T.-F., & Oh, W. (2005) · Pediatrics · doi:10.1542/peds.2004-1463 · Cited by 660
Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · cited 3×
“In an attempt to investigate this issue, one small study used culture-independent techniques in a patient with recurrent CDI who received faecal microbial reconstitution (Khoruts et al., 2010).”
BackgroundInfluentialShort-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500701 · Cited by 614 · cited 2×
“…to similar antibiotic-associated infections such as CDI and one small trial of the use of oral vancomycin in a group of severely autistic children reported impressive developmental gains during treatment that diminished Beneficial Microbes 4(1) 61 when the drug was withdrawn (Sandler et al., 2000).”
BackgroundOral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Neonates
Bin-Nun, A., Bromiker, R., Wilschanski, M., Kaplan, M., Rudensky, B., Caplan, M., & Hammerman, C. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.03.054 · Cited by 590
Lin, H.-C., Hsu, C.-H., Chen, H.-L., Chung, M.-Y., Hsu, J.-F., Lien, R.-I., Tsao, L.-Y., Chen, C.-H., & Su, B.-H. (2008) · Pediatrics · doi:10.1542/peds.2007-3007 · Cited by 506 · cited 1×
“Clinical trials using mixtures of probiotic organisms such as Infloran® (Lactobacillus acidophilus and Bifidobacterium infantis) (Hoyos, 1999; Lin et al., 2005, 2008) and ABC Dophilus® (B. infantis, Streptococcus thermophilus and Bifidobacterium bifidus (Bin-Nun et al., 2005)) have also shown…”
BackgroundWang, L., Christophersen, C. T., Sorich, M. J., Gerber, J. P., Angley, M. T., & Conlon, M. A. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05212-11 · Cited by 432 · cited 2×
“…of Clostridium spp. (Finegold et al., 2010; Parracho et al., 2005), Desulfovibrio spp. (Finegold, 2011a) and Sutterella spp. (Williams et al., 2012), and under-representation of Akkermansia muciniphila and Bifidobacterium spp. (Wang et al., 2011), the significance of which has yet to be defined.”
BackgroundWilliams, B. L., Hornig, M., Parekh, T., & Lipkin, W. I. (2012) · mBio · doi:10.1128/mbio.00261-11 · Cited by 378 · cited 1×
“…over-representation of Clostridium spp. (Finegold et al., 2010; Parracho et al., 2005), Desulfovibrio spp. (Finegold, 2011a) and Sutterella spp. (Williams et al., 2012), and under-representation of Akkermansia muciniphila and Bifidobacterium spp. (Wang et al., 2011), the significance of which…”
BackgroundMacFabe, D. F., Cain, N. E., Boon, F., Ossenkopp, K.-P., & Cain, D. P. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.10.005 · Cited by 365
Voices from within: gut microbes and the CNS
Forsythe, P., & Kunze, W. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1028-z · Cited by 336 · cited 2×
“The gut-brain-microbiota axis is a relatively new term coined to describe the increasingly clear interactions between these three systems (Forsythe and Kunze, 2012).”
BackgroundGut Microbiota, Intestinal Permeability, Obesity‐Induced Inflammation, and Liver Injury
Frazier, T. H., DiBaise, J. K., & McClain, C. J. (2011) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607111413772 · Cited by 306 · cited 1×
“The involvement of the gut microbiota in obesity is one of the environmental factors that has recently come under scrutiny (Frazier et al., 2011; Greenblum et al., 2012; Harris et al., 2012; Kaplan and Walker, 2012; Thompson, 2012).”
BackgroundCultivable bacterial diversity from the human colon
Duncan, S. H., Louis, P., & Flint, H. J. (2007) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2007.02129.x · Cited by 279 · cited 1×
“However, this widely promoted figure is likely to be a gross underestimate of the culturable species present in this niche (Duncan et al., 2007).”
BackgroundUlcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
Noor, S. O., Ridgway, K., Scovell, L., Kemsley, E. K., Lund, E. K., Jamieson, C., Johnson, I. T., & Narbad, A. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-134 · Cited by 227 · cited 1×
“A reduction in the richness, evenness and overall diversity of the microbiota has been reported in children and adolescents with UC compared to either healthy controls or siblings (Andoh et al., 2011; Michail et al., 2011; Nemoto et al., 2012; Noor et al., 2010).”
BackgroundBolte, E. R. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90107-4 · Cited by 213
Microbiology of regressive autism
Finegold, S. M., Downes, J., & Summanen, P. H. (2012) · Anaerobe · doi:10.1016/j.anaerobe.2011.12.018 · Cited by 211
Thomas, R. H., Meeking, M. M., Mepham, J. R., Tichenoff, L., Possmayer, F., Liu, S., & MacFabe, D. F. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-153 · Cited by 200 · cited 1×
“They hypothesise that an excess of propionic acid resulting from gut dysbiosis and resultant excessive fermentation by certain members of the gut microbiota may be at the source of this (MacFabe et al., 2011; Thomas et al., 2012).”
BackgroundDesulfovibrio species are potentially important in regressive autism
Finegold, S. M. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.04.032 · Cited by 197 · cited 2×
“…to age-matched controls, including over-representation of Clostridium spp. (Finegold et al., 2010; Parracho et al., 2005), Desulfovibrio spp. (Finegold, 2011a) and Sutterella spp. (Williams et al., 2012), and under-representation of Akkermansia muciniphila and Bifidobacterium spp. (Wang et…”
BackgroundWright, D. P., Rosendale, D. I., & Roberton, A. M. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09265.x · Cited by 185 · cited 2×
“Since organisms such as Bacteroides and Prevotella produce sulphatases, which are capable of degrading mucin (Tsai et al., 1992; Wright et al., 2000), it is plausible that these bacterial communities may play a role in the pathogenesis of UC by interfering with normal barrier function and affecting…”
BackgroundRegression in Autistic Spectrum Disorders
Stefanatos, G. A. (2008) · Neuropsychology Review · doi:10.1007/s11065-008-9073-y · Cited by 161
A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics
Allen-Vercoe, E., Reid, G., Viner, N., Gloor, G. B., Hota, S., Kim, P., Lee, C., O’Doherty, K. C., Vanner, S. J., Weese, J. S., et al. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/213828 · Cited by 81 · cited 2×
“…revealed that faecal bacteriotherapy treatments of one form or another have been performed in at least 6 major cities in Canada; the attendees at the meeting had collectively performed over 220 faecal bacteriotherapy transplants in total, with cure rates over 90% (Allen-Vercoe et al., 2012).”
BackgroundSelf-citation
Research works printed but not linked: 66
- 10.1007/s00535-010-0368-4 · DOI · Paper page
- 10.1038/nature09944 · DOI · Paper page
- 10.1016/j.anaerobe.2009.09.007 · DOI · Paper page
- 10.1086/521863 · DOI · Paper page
- Pediatrics, 63, 425, 10.1542/peds.63.3.425 · doi:10.1542/peds.63.3.425
- 10.1586/egh.11.71 · DOI
- 10.1097/00004836-200307000-00012 · DOI · Paper page
- 10.1016/S0016-5085(99)70450-6 · DOI · Paper page
- 10.1096/fj.00-0833hyp · DOI · Paper page
- 10.1152/ajpgi.00557.2006 · DOI
- 10.1016/j.febslet.2012.01.049 · DOI · Paper page
- 10.1542/peds.2007-3423 · DOI · Paper page
- 10.1126/science.1110591 · DOI · Paper page
- Surgery, 44, 854
- 10.1016/j.anaerobe.2011.03.007 · DOI
- 10.1111/j.1462-2920.2007.01281.x · DOI · Paper page
- 10.1177/0148607110381270 · doi:10.1177/0148607110381270
- 10.1086/521861 · DOI · Paper page
- 10.1016/S0022-3476(78)80523-X · DOI · Paper page
- 10.1097/MPG.0b013e31822d53e5 · DOI
- 10.1093/cid/cir632 · DOI · Paper page
- 10.1073/pnas.1116053109 · DOI · Paper page
- 10.1111/j.1365-2036.2012.05033.x · DOI · Paper page
- Journal of Obesity, 2012, 879151
- 10.1111/j.1574-6941.2002.tb00904.x · doi:10.1111/j.1574-6941.2002.tb00904.x · Paper page
- 10.1016/S1201-9712(99)90024-3 · DOI · Paper page
- Gastroenterology and Hepatology, 2, 203
- 10.3945/ajcn.110.010132 · DOI · Paper page
- 10.1097/MCO.0b013e32835133cb · DOI
- 10.1001/archinte.172.2.191 · DOI
- 10.1016/S0140-6736(00)04234-3 · DOI · Paper page
- 10.1152/ajpgi.00141.2009 · DOI · Paper page
- 10.1097/MCG.0b013e3182431d78 · DOI · Paper page
- Acta Paediatrica, 396, 2
- 10.1053/j.gastro.2011.04.011 · DOI · Paper page
- 10.1073/pnas.0504978102 · DOI · Paper page
- 10.1038/4441022a · DOI · Paper page
- 10.1099/jmm.0.46198-0 · DOI · Paper page
- 10.1016/S0031-3955(16)38622-9 · DOI
- 10.1136/adc.67.1_Spec_No.53 · DOI
- 10.1097/00006454-199002000-00005 · doi:10.1097/00006454-199002000-00005
- 10.1179/1476830512Y.0000000003 · DOI · Paper page
- 10.12968/hmed.2012.73.5.265 · doi:10.12968/hmed.2012.73.5.265
- 10.1038/nature08821 · DOI · Paper page
- 10.1016/S0022-3476(99)70452-X · doi:10.1016/s0022-3476(99)70452-x
- 10.4161/gmic.2.3.16333 · DOI · Paper page
- Annals of Clinical Psychiatry, 21, 205
- Infection and Immunity, 45, 185, 10.1128/IAI.45.1.185-191.1984 · DOI · Paper page
- 10.1203/01.PDR.0000078274.74607.7A · DOI · Paper page
- 10.1016/j.tim.2007.12.008 · DOI · Paper page
- 10.1542/peds.2009-2959 · DOI · Paper page
- Pediatrics, 66, 928, 10.1542/peds.66.6.928 · DOI
- Applied and Environmental Microbiology, 65, 4799, 10.1128/AEM.65.11.4799-4807.1999 · DOI · Paper page
- 10.1038/ajg.2011.58 · DOI · Paper page
- 10.1002/ajhb.22254 · DOI
- 10.1136/gut.36.4.570 · DOI · Paper page
- 10.1042/cs0820447 · DOI · Paper page
- 10.1038/nature07540 · DOI · Paper page
- 10.1038/nature06244 · DOI · Paper page
- 10.1038/nature05414 · DOI · Paper page
- 10.1016/S0140-6736(89)92749-9 · DOI · Paper page
- 10.1111/j.1574-6976.2011.00270.x · DOI · Paper page
- Advances in Experimental Medicine and Biology, 635, 41
- 10.1038/ismej.2009.37 · DOI · Paper page
- 10.1126/science.1208344 · DOI · Paper page
- 10.1021/pr901188e · DOI · Paper page
Cited by
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Brennan, C. A., & Garrett, W. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0129-6 · Cited by 1,205
De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D. I., Cristofori, F., Guerzoni, M. E., Gobbetti, M., & Francavilla, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076993 · Cited by 887
“To the best of our knowledge, a more in depth characterization of the GI microbiota and related metabolome is strongly needed for AD patients, as well as the role of bacteria during AD development and treatment has to be highlighted [15].”
BackgroundThe Impact of Food Bioactives on Health
(2015) · Springer eBooks · doi:10.1007/978-3-319-16104-4 · Cited by 805
Clostridium species as probiotics: potentials and challenges
Guo, P., Zhang, K., Ma, X., & He, P. (2020) · Journal of Animal Science and Biotechnology · doi:10.1186/s40104-019-0402-1 · Cited by 597
Metadata
- Authors
- Petrof, E. O., Claud, E. C., Gloor, G. B., & Allen-Vercoe, E.
- Venue
- Beneficial Microbes
- Publisher
- Walter de Gruyter GmbH
- Published
- 2013-03-01
- Volume
- 4
- Issue
- 1
- Pages
- 53-65
- ISSN
- 1876-2883 (ISSN-L)
- 1876-2891
- OpenAlex
- W1975288924
- Cited by
- 123
- References
- 32
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.